Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;7(4):e35424.
doi: 10.1371/journal.pone.0035424. Epub 2012 Apr 23.

DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder

Affiliations

DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder

Bjarte Håvik et al. PLoS One. 2012.

Abstract

Doublecortin and calmodulin like kinase 1 (DCLK1) is implicated in synaptic plasticity and neurodevelopment. Genetic variants in DCLK1 are associated with cognitive traits, specifically verbal memory and general cognition. We investigated the role of DCLK1 variants in three psychiatric disorders that have neuro-cognitive dysfunctions: schizophrenia (SCZ), bipolar affective disorder (BP) and attention deficit/hyperactivity disorder (ADHD). We mined six genome wide association studies (GWASs) that were available publically or through collaboration; three for BP, two for SCZ and one for ADHD. We also genotyped the DCLK1 region in additional samples of cases with SCZ, BP or ADHD and controls that had not been whole-genome typed. In total, 9895 subjects were analysed, including 5308 normal controls and 4,587 patients (1,125 with SCZ, 2,496 with BP and 966 with ADHD). Several DCLK1 variants were associated with disease phenotypes in the different samples. The main effect was observed for rs7989807 in intron 3, which was strongly associated with SCZ alone and even more so when cases with SCZ and ADHD were combined (P-value = 4 × 10(-5) and 4 × 10(-6), respectively). Associations were also observed with additional markers in intron 3 (combination of SCZ, ADHD and BP), intron 19 (SCZ+BP) and the 3'UTR (SCZ+BP). Our results suggest that genetic variants in DCLK1 are associated with SCZ and, to a lesser extent, with ADHD and BP. Interestingly the association is strongest when SCZ and ADHD are considered together, suggesting common genetic susceptibility. Given that DCLK1 variants were previously found to be associated with cognitive traits, these results are consistent with the role of DCLK1 in neurodevelopment and synaptic plasticity.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Association of DCKL1 genetic variants with psychiatric and cognitive traits.
Markers are ordered from 5′ to 3′ of the gene, anti-sense to the reference sequence. A. Representation of the genomic region covered and of 6 DCLK1 transcripts (from top to bottom: DCL, CARP, 2 short variants and 2 long variants). In addition to alternative start sites, the transcripts can be alternatively spliced for part of exon 9, for exon 19 and in the 3′UTR. B. All markers showing nominal association to psychiatric traits in this study or to cognitive traits in our previous study are displayed. Color code: yellow, P-value between 0.05 and 0.001; orange, P-value between 0.001 and 0.0001; red, P-value<0.0001; white, P-value>0.05; grey, marker not tested in this sample. The markers used in the cross-phenotype analyses are highlighted in red. C. LD between the markers used in the cross-phenotype analyses, and the markers associated with cognitive traits in our previous study . LD is displayed using a r2 scale ranging from r2 = 1 in black to r2 = 0 in white.

References

    1. Gur RE, Calkins ME, Gur RC, Horan WP, Nuechterlein KH, et al. The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophr Bull. 2007;33:49–68. - PMC - PubMed
    1. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12:426–445. - PubMed
    1. Kalkstein S, Hurford I, Gur RC. Neurocognition in schizophrenia. Curr Top Behav Neurosci. 2010;4:373–390. - PubMed
    1. Kuntsi J, McLoughlin G, Asherson P. Attention deficit hyperactivity disorder. Neuromolecular Med. 2006;8:461–484. - PubMed
    1. McIntyre R. Bipolar disorder and ADHD: Clinical concerns. CNS Spectr. 2009;14:8–9; discussion 13–14. - PubMed

Publication types

MeSH terms

Substances